These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31895304)

  • 1. Performance of an Alternative Laboratory-Based HIV Diagnostic Testing Algorithm Using HIV-1 RNA Viral Load.
    Pitasi MA; Patel SN; Wesolowski LG; Masciotra S; Luo W; Owen SM; Delaney KP
    Sex Transm Dis; 2020 May; 47(5S Suppl 1):S18-S25. PubMed ID: 31895304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Routine HIV Test Results in 6 US Clinical Laboratories Using the Recommended Laboratory HIV Testing Algorithm With Geenius HIV 1/2 Supplemental Assay.
    Wesolowski LG; Chavez PR; Cárdenas AM; Katayev A; Slev P; Valsamakis A; Wang YF; Yao JD; Dougherty C; Gillim-Ross L; Harmon C; Delaney KP
    Sex Transm Dis; 2020 May; 47(5S Suppl 1):S13-S17. PubMed ID: 32343517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of the new HIV-1/2 diagnostic algorithm in Florida's public health testing population: a review of the first five months of utilization.
    Bennett B; Neumann D; Fordan S; Villaraza R; Crowe S; Gillis L
    J Clin Virol; 2013 Dec; 58 Suppl 1():e29-33. PubMed ID: 24342476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid Testing Algorithm Performance in a Low-Prevalence Environment.
    Martin EG; Cornett J; Mohammed DY; Salaru G
    Sex Transm Dis; 2020 May; 47(5S Suppl 1):S35-S40. PubMed ID: 31977973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BioRad BioPlex® HIV Ag-Ab assay: Incidence of false positivity in a low-prevalence population and its effects on the current HIV testing algorithm.
    Parker J; Carrasco AF; Chen J
    J Clin Virol; 2019 Jul; 116():1-3. PubMed ID: 30981082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of an alternative laboratory-based algorithm for diagnosis of HIV infection utilizing a third generation immunoassay, a rapid HIV-1/HIV-2 differentiation test and a DNA or RNA-based nucleic acid amplification test in persons with established HIV-1 infection and blood donors.
    Wesolowski LG; Delaney KP; Hart C; Dawson C; Owen SM; Candal D; Meyer WA; Ethridge SF; Branson BM
    J Clin Virol; 2011 Dec; 52 Suppl 1():S45-9. PubMed ID: 21995934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of the Alere Determine™ HIV-1/2 Ag/Ab Combo Rapid Test with algorithm-defined acute HIV-1 infection specimens.
    Parker MM; Bennett SB; Sullivan TJ; Fordan S; Wesolowski LG; Wroblewski K; Gaynor AM
    J Clin Virol; 2018 Jul; 104():89-91. PubMed ID: 29803089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Could HIV-1 RNA Testing be an Option as the Second Step in the HIV Diagnostic Algorithm?
    Masciotra S; Luo W; Rossetti R; Smith T; Ethridge S; Delaney KP; Wesolowski LG; Owen SM
    Sex Transm Dis; 2020 May; 47(5S Suppl 1):S26-S31. PubMed ID: 31977972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of an alternative laboratory-based algorithm for HIV diagnosis in a high-risk population.
    Delaney KP; Heffelfinger JD; Wesolowski LG; Owen SM; Meyer WA; Kennedy S; Uniyal A; Kerndt PR; Branson BM
    J Clin Virol; 2011 Dec; 52 Suppl 1():S5-10. PubMed ID: 22019251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of an alternative HIV diagnostic algorithm using the ARCHITECT HIV Ag/Ab Combo assay and potential utility of sample-to-cutoff ratio to discriminate primary from established infection.
    Ramos EM; Harb S; Dragavon J; Swenson P; Stekler JD; Coombs RW
    J Clin Virol; 2013 Dec; 58 Suppl 1(0 1):e38-43. PubMed ID: 24029686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance evaluation of the FDA-approved Determine™ HIV-1/2 Ag/Ab Combo assay using plasma and whole blood specimens.
    Masciotra S; Luo W; Westheimer E; Cohen SE; Gay CL; Hall L; Pan Y; Peters PJ; Owen SM
    J Clin Virol; 2017 Jun; 91():95-100. PubMed ID: 28372891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleic acid testing by public health referral laboratories for public health laboratories using the U.S. HIV diagnostic testing algorithm.
    Wesolowski LG; Wroblewski K; Bennett SB; Parker MM; Hagan C; Ethridge SF; Rhodes J; Sullivan TJ; Ignacio-Hernando I; Werner BG; Owen SM
    J Clin Virol; 2015 Apr; 65():6-10. PubMed ID: 25766979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of turnaround time and total cost of HIV testing before and after implementation of the 2014 CDC/APHL Laboratory Testing Algorithm for diagnosis of HIV infection.
    Chen DJ; Yao JD
    J Clin Virol; 2017 Jun; 91():69-72. PubMed ID: 28461133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of early HIV infections using the fourth generation Abbott ARCHITECT HIV Ag/Ab Combo chemiluminescent microparticle immunoassay (CIA) in San Diego County.
    Manlutac AL; Giesick JS; McVay PA
    J Clin Virol; 2013 Dec; 58 Suppl 1():e44-7. PubMed ID: 24342477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of rapid HIV assays as supplemental tests in specimens with repeatedly reactive screening immunoassay results not confirmed by HIV-1 Western blot.
    Wesolowski LG; Delaney KP; Meyer WA; Blatt AJ; Bennett B; Chavez P; Granade TC; Owen M
    J Clin Virol; 2013 Sep; 58(1):240-4. PubMed ID: 23838670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of the Bio-Rad Geenius HIV-1/2 Confirmatory Assay and the Bio-Rad Multispot HIV-1/2 Rapid Test as an alternative differentiation assay for CLSI M53 algorithm-I.
    Malloch L; Kadivar K; Putz J; Levett PN; Tang J; Hatchette TF; Kadkhoda K; Ng D; Ho J; Kim J
    J Clin Virol; 2013 Dec; 58 Suppl 1():e85-91. PubMed ID: 24342484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative performance of the Geenius™ HIV-1/HIV-2 supplemental test in Florida's public health testing population.
    Fordan S; Bennett B; Lee M; Crowe S
    J Clin Virol; 2017 Jun; 91():79-83. PubMed ID: 28434810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of fourth-generation ARCHITECT HIV Ag/Ab Combo assay and utility of signal-to-cutoff ratio to predict false-positive HIV tests in pregnancy.
    Adhikari EH; Macias D; Gaffney D; White S; Rogers VL; McIntire DD; Roberts SW
    Am J Obstet Gynecol; 2018 Oct; 219(4):408.e1-408.e9. PubMed ID: 29913173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of three FDA-approved HIV Ag/Ab combination tests using a genetically diverse HIV panel and diagnostic specimens.
    Qiu X; Sokoll L; Yip P; Elliott DJ; Dua R; Mohr P; Wang XY; Spencer M; Swanson P; Dawson GJ; Hackett J
    J Clin Virol; 2017 Jul; 92():62-68. PubMed ID: 28535437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of the Alere Determine™ HIV-1/2 Ag/Ab Combo Rapid Test with specimens from HIV-1 seroconverters from the US and HIV-2 infected individuals from Ivory Coast.
    Masciotra S; Luo W; Youngpairoj AS; Kennedy MS; Wells S; Ambrose K; Sprinkle P; Owen SM
    J Clin Virol; 2013 Dec; 58 Suppl 1(Suppl 1):e54-8. PubMed ID: 23911678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.